Catalyst Wire Dossier Catalyst Wire Dossier

LEVETIRACETAM ER

LEVETIRACETAM · Westminster Pharmaceuticals, LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LEVETIRACETAM ER, covering 2020-11-27 to 2024-08-26. Get the full timeline:

Most recent: FDA Approved: LEVETIRACETAM ER — Supplemental Application (Westminster Pharmaceuticals, LLC)

See pricing